Adipositas - Ursachen, Folgeerkrankungen, Therapie, Table of Contents Adipositas - Ursachen, Folgeerkrankungen, Therapie 2011; 05(03): 01DOI: 10.1055/s-0037-1618753 Gestationsdiabetes Schattauer GmbH Epidemiologie des Gestationsdiabetes H. Kleinwechter Recommend Article Abstract Buy Article Full Text References Literatur 1 Agarwal M, Dhatt G, Punnose J, Koster G. Gestational diabetes: a dilemma cuased by multiple international diagnostic criteria. Diabet Med 2005; 22: 1731-1736. 2 AG Diabetes und Schwangerschaft der DDG, AG Materno-Fetale Medizin der DGGG und DGPM. Diagnostik und Therapie des Gestationsdiabetes (GDM). Frauenarzt 2001; 42: 691-699. 3 American Diabetes Association. Standards of Medical Care in Diabetes – 2011. Diabetes Care 2011; 34 (Suppl. 01) S11-S61. 4 AQUA – Institut für angewandte Qualitätsför-derung und Forschung im Gesundheitswesen GmbH. Bundesauswertung zum Verfahrensjahr 2009 16/1 – Geburtshilfe Qualitätsindikatoren. Erstellt am: 15.06.2010 – 11051a. 5 Bellamy L, Casas J, Hingorani A, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373: 1773-1779. 6 Bruns D, Knowler W. Stabilization of Glucose in Blood Samples: Why It Matters. Clin Chem 2009; 55: 850-852. 7 Carpenter M, Coustan D. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768-773. 8 Crowther C. et al. (ACHOIS Trial Group). Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes. N Engl J Med 2005; 352: 2477-2486. 9 Fachkommission Diabetes Sachsen. Diabetes und Schwangerschaft. Meißen: Thieme; 1999: s10-12. 10 HAPO Study Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Obstet Gynecol Obstet 2002; 78: 69-77. 11 Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. NEJM 2008; 358: 1991-2002. 12 Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: Associations with Neonatal Anthropometrics. Diabetes 2009; 58: 453-459. 13 Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol. 2010 202:o255.e1–7. 14 International Association of Diabetes and Pregancy Study Groups Consensus Panel. International Association of Diabetes and Pregancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 2010; 33: 676-682. 15 Kautzky-Willer A, Bancher-Todesca D, Djelmis J, Desoye G, Ivanisevic M. (Hrsg) Diabetology of pregnancy. Endocrine changes in diabetic pregnancy. Front Diabetes. Basel: Karger; 2005: 18-33. 16 Kautzky-Willer A, Bancher-Todesca D, Repa A. et al. Gestationsdiabetes (GDM). Wien Klin Wochenschr 2009; 121 (Suppl. 05) S51-S56. 17 Kerner W. Brückel J. Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie 2010; 05 (Suppl. 02) S109-S112. 18 Kim C, Newton K, Knopp R. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25: 1862-1868. 19 King H. Epidemiology of Glucose Intolerance and Gestational Diabetes in Women in Childbearing Age. Diabetes Care 1998; 21 (Suppl. 02) B9-B13. 20 Kleinwechter H, Demandt N, Schäder-Graf U. Gestationsdiabetes. Neue Erkenntnisse durch neue Studien. Internist Praxis 2010; 50: 55-66. 21 Kleinwechter H, Schäfer-Graf U, Bührer B. et al. Gestationsdiabets mellitus (GDM). Evidenzbasierte Leitlinie zu Diagnostik, Therapie und Nachsorge. http://www.deutsche-diabetesgesellschaft.de/redaktion/news/EbLL_GDM_ENDFAS-SUNG_2011_01_28_E1.pdf. 22 Landon M. et al. for the Eunice Kennedy Shriver Nationale Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Network. A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes. NEJM 2009; 361: 1339-1348. 23 Lehmann R, Troendle A, Brändle M. Schweizerischen Gesellschaft für Endokrinologie und Diabetologie. New insights into diagnosis and management of gestational diabetes mellitus: recommendations of the Swiss Society for Endocrinology and Diabetes. Ther Umsch 2009; 66: 695-706. 24 Löbner K, Knopff A, Baumgarten A. et al. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006; 55: 792-797. 25 Murgia C, Berria R, Minerba L. et al. Gestational diabetes mellitus in Sardinia: Results from an early, universal screening procedure. Diabetes Care 2006; 29: 1713-1714. 26 Nesbitt S, Smye M, Sgeridan B, Lappin T, Trimble E. Intergration of local and central laboratory functions in a worldwide multicenter study: Experience from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Clinical Trials 2006; 03: 397-407. 27 Ricart W. et al. Spanish Group for the Study of the Impact of Carpenter and Coustan GDM thresholds. Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain. Diabetologia 2005; 48: 1135-1141. 28 Stahl M, Brandslund L, Jørgensen L. et al. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus?. Scand J Clin Lab Invest 2002; 62: 159-166. 29 Swai A, Kitange H, McLarty D. et al. No detoriation of oral glucose tolerance during pregnancy in rural Tanzania. Diabet Med 1991; 08: 254-257. 30 Watanabe R, Allayee H, Xiang A. et al. Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes 2007; 56: 1481-1485. 31 Xiang A, Kjos S, Takayanagi M, Trigo E, Buchanan T. Detailed Physiological Characterization of the Development of Type 2 Diabetes in Hispanic Women With Prior Gestational Diabetes Mellitus. Diabetes 2010; 59: 2625-2630.
